CONSULTA E SCARICA I NOSTRI ARTICOLI

ARTICOLI PUBBLICATI

Menichelli D, Gazzaniga G, Antonucci E, Palareti G, Poli D, Pignatelli P, Pastori D; START2 Register Investigators. Effectiveness of direct oral anticoagulants for all-cause mortality and cardiovascular events in overweight and obese patients with atrial fibrillation: Insight from the nationwide START registry.  Eur J Clin Invest. 2025

Menichelli D, Gazzaniga G, Poli D, Palareti G, Antonucci E, Pani A, Pignatelli P, Pastori D; START2 Register Investigators. Real-world use of direct oral anticoagulants in atrial fibrillation patients with moderate/severe chronic kidney disease: a propensity score matched analysis from the START registry. Clin Res Cardiol. 2025

Pengo V, Sarti L, Poli D, Sivera P, Barcellona D, Prisco D, Pizzini AM, Vercillo G, Antonucci E, Palareti G; Start2 Antiphospholipid Registry collaborators.  Application of ACR/EULAR Classification Criteria in Real Life: Thrombotic Patients Positive for Lupus Anticoagulant Only. Semin Thromb Hemost. 2025

Menichelli D, Antonucci E, Poli D, Baratta F, Sciacqua A, Armentaro G, Gazzaniga G, Moscucci F, Palareti G, Farcomeni A, Ettorre E, Desideri G, Violi F, Pignatelli P, Pastori D; START2 Register Investigators. Frailty elements, direct oral anticoagulants and mortality risk in atrial fibrillation patients aged ≥ 80 or ≥ 90 years from the nationwide Italian START registry: a propensity score matching analysis. Geroscience. 2025

Stefania Cavazza, Gualtiero Palareti  Still unmet problems with low molecular weight heparin prophylaxis of venous thromboembolism. An Italian survey. BTVB 2025

Menichelli D, Antonucci E, Gazzaniga G, Poli D, Armentaro G, di Carlo G, Marcucci R, Calabrò P, Cesaro A, Palareti G, Sciacqua A, Pignatelli P, Pastori D; START 2 Collaborators* Atrial Fibrillation, Heart Failure Phenotypes, and Mortality Risk in the Nationwide START Registry: A Propensity Score Matching Analysis. J Am Heart Assoc. 2025

Aiello A, Sarti L, Sandri G, Poli D, Sivera P, Barcellona D, Prisco D, Pizzini AM, Vercillo G, Antonucci E, Palareti G, Pengo V; Start2 Antiphospholipid Registry collaborators. Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid Registry. Int J Lab Hematol. 2025

Palareti G, Legnani C, Testa S, Paoletti O, Cini M, Antonucci E, Pengo V, Poli D, Ageno W, Prandoni P, Prisco D, Tosetto A; MAS Working Group. Can the Charlson comorbidity index help to guide DOAC dosing in patients with atrial fibrillation and improve the efficacy and safety of treatment? A subanalysis of the MAS study. Curr Probl Cardiol. 2025

De Sio V, Gragnano F, Capolongo A, Guarnaccia N, Maddaluna P, Acerbo V, Galli M, Berteotti M, Sperlongano S, Cesaro A, Moscarella E, Pelliccia F, Patti G, Antonucci E, Cirillo P, Pignatelli P, Palareti G, Pengo V, Gresele P, Marcucci R, Calabrò P. Eligibility for and practical implications of Semaglutide in overweight and obese patients with acute coronary syndrome. Int J Cardiol  2025

Cirillo P, Di Serafino L, Scalamogna M, De Rosa G, Calabrò P, Antonucci E, Gresele P, Palareti G, Patti G, Pengo V, Pignatelli P, Marcucci R. ACEF vs PARIS score in Predicting Cardiovascular Events in Patients With Acute Coronary Syndrome: Insights From the START ANTIPLATELET Registry. Angiology. 2024

Cirillo P, Di Serafino L, Scalamogna M, De Rosa G, Calabrò P, Antonucci E, Gresele P, Palareti G, Patti G, Pengo V, Pignatelli P, Marcucci R. ACEF vs PARIS score in Predicting Cardiovascular Events in Patients With Acute Coronary Syndrome: Insights From the START ANTIPLATELET Registry. Angiology. 2024

Palareti G, Testa S, Legnani C, Paoletti O, Cini M, Antonucci E, Pengo V, Poli D, Ageno W, Prandoni P, Prisco D, Tosetto A; MAS Study group. The use of reduced DOAC doses in atrial fibrillation patients does not always lead to good anticoagulation levels and avoid adverse events. Int J Cardiol. 2024

Parisi R, Antonucci E, Bucherini E, Chistolini A, Di Giorgio A, Di giulio R, Mastroiacovo D, Marzolo M, Pancani R, Pastori D, Podda GM, Sivera P, Poli D, Palareti G. Venous Thromboembolism: A Chronic Disease. Journ Clin Med Case Studies 2024

Gresele P, Guglielmini G, Del Pinto M, Calabrò P, Pignatelli P, Patti G, Pengo V, Antonucci E, Cirillo P, Fierro T, Palareti G, Marcucci R; START Antiplatelet Registry Group. Low platelet count at admission has an adverse impact on outcome in patients with acute coronary syndromes: from the START Antiplatelet registry.Sci Rep. 2024

Palareti G, Legnani C, Tosetto A, Poli D, Testa S, Ageno W, Pengo V, Cosmi B, Prandoni P. D-dimer and risk of venous thromboembolism recurrence: Comparison of two studies with similar designs but different laboratory and clinical results. Thromb Res 2024

Bernardini A, Bindini L, Antonucci E, Berteotti M, Giusti B, Testa S, Palareti G, Poli D, Frasconi P, Marcucci R. Machine learning approach for prediction of outcomes in anticoagulated patients with atrial fibrillation. Int J Cardiol. 2024

Palareti G, Testa S, Legnani C, Dellanoce C, Cini M, Paoletti O, Ciampa A, Antonucci E, Poli D, Morandini R, Tala M, Chiarugi P, Santoro RC, Iannone AM, De Candia E, Pignatelli P, Faioni EM, Chistolini A, Esteban MDP, Marietta M, Tripodi A, Tosetto A, for the MAS Study Group. More Early Bleeds Associated With High Baseline Direct Oral Anticoagulant Levels In Atrial Fibrillation: The MAS Study. Blood Adv. 2024

Poli D, Antonucci E, Ageno W, Berteotti M, Falanga A, Pengo V, Chiarugi P, Cosmi B, Paparo C, Chistolini A, Insana A, Lione D, Malcangi G, Martini G, Masciocco L, Pedrini S, Bucherini E, Pastori D, Pignatelli P, Toma A, Testa S, Palareti G, Start AF Study Group.Inappropriate Underdosing of Direct Oral Anticoagulants in Atrial Fibrillation Patients: Results from the START2-AF Registry. J Clin Med. 2024

Palareti G, Antonucci E, Bucherini E, Caronna A, Chistolini A, Di Giorgio A, Di Giulio R, Falanga A, Fregoni V, Garzia M, Mastroiacovo D, Marzolo M, Pancani R, Pastori D, Podda GM, Rigoni AM, Ria L, Sivera P, Testa S, Visonà A, Parisi R, Poli D, On Behalf Of The Start Post Vte Investigators. Long-Term Outcomes in Two-Year Follow-Up after Primary Treatment in Patients with a Prior Venous Thromboembolic Event: A Prospective, Observational, Real-Life Study.J Clin Med. 2024

Pengo V, Sarti L, Antonucci E, Bison E, Pontara E, Cattini MG, Denas G, Poli D, Palareti G. Patients with antiphospholipid syndrome and a first venous or arterial thrombotic event: clinical characteristics, antibody profiles and estimate of the risk of recurrence. Clin Chem Lab Med. 2024

Testa S, Palareti G, Legnani C, Dellanoce C, Cini M, Paoletti O, Ciampa A, Antonucci E, Poli D, Morandini R, Tala M, Chiarugi P, Santoro RC, Iannone AM, De Candia E, Pignatelli P, Faioni EM, Chistolini A, Esteban MDP, Marietta M, Tripodi A, Tosetto A.Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study. Blood Adv. 2024

Rostagno C, Rubbieri G, Zeppa M, Cartei A, Ceccofiglio A, Mannarino GM, Palareti G, Grandone E.Management and 1-Year Outcome in Elderly Patients with Hip Fracture Surgery Receiving Anticoagulation (Warfarin or DOAc) or P2Y12 Antiplatelet Agents. J Clin Med. 2023

 Menichelli D, Poli D, Antonucci E, Palareti G, Pignatelli P, Pastori D. Renin-angiotensin-aldosterone system inhibitors and mortality risk in elderly patients with atrial fibrillation. Insights from the nationwide START registry. Eur J Intern Med. 2023

Pengo V  Sarti L, Antonucci E, Di Agostino S, Bison E, Denas G, Poli D, Meroni PL Gerli R, Radice A, Palareti G. Descriptive analysis of patients positive for anti-phospholipid antibodies included in two Italian registries. BTVB 2023

Menichelli D, Antonucci E, Pignatelli P, Violi F, Palareti G, Pastori D; START2 Register Investigators. Statins under-treatment and mortality in patients with atrial fibrillation. Insights from the nationwide START registry. Nutr Metab Cardiovasc Dis. 2023

Guarascio M, Bertù L, Donadini MP, Antonucci E, Palareti G, Ageno W. DOACs use in extreme body-weighted patients: results from the prospective START-register. Intern Emerg Med. 2023

Poli D, Ageno W, Antonucci E, Bradamante S Bucherini E, Chiarugi P, Chistolini A, Cosmi B , Falanga A, Insana A, Lione D, Lombardi MR, Malcangi G, Marcucci R,   Martini G, Masciocco L, Paparo C, Pastori D, Pedrini S, Pengo V, Pignatelli P, Toma A testa S, Palareti G. Management of anticoagulation in atrial fibrillation patients in Italy: insight from the Atrial Fibrillation-Survey on Anticoagulated Patients Register (AF-START). BTVB 2023

Grandone E, Antonucci E, Colaizzo D, De Laurenzo A, Cosmi B, Cini M, Legnani C, Testa S, Margaglione M, Palareti G. Venous thromboembolism in women of childbearing age: insights from the START registry. Thromb Haemost. 2023

Ageno W, Antonucci E, Poli D, Bucherini E, Chistolini A, Fregoni V, Lerede T, Pancani R, Pedrini S, Pieralli F, Pignatelli P, Pizzini AM, Podda GM, Potere N, Sarti L, Testa S, Visonà A, Palareti G; START 2 Registry VTE study group.  Venous thromboembolism secondary to hospitalization for COVID-19: patient management and long-term outcomes. Res Pract Thromb Haemost. 2023

Palareti G, Legnani C, Poli D, Ageno W, Pengo V, Testa S, Tosetto A, Prandoni P; NEUROFARBA, University of Florence, Italy. COVID-19 pandemic affects the ability of negative D-dimer to identify venous thromboembolism patients at low risk of recurrence: insights from the Apidulcis study. Haematologica 2023

Prandoni P, Lensing AWA, Prins MH, Ciammaichella M, Pirillo S, Pace F, Zalunardo B, Bottino F, Ageno W, Muiesan ML, Forlin M, Depietri L, Bova C, Costantini N, Caviglioli C, Migliaccio L, Noventa F, Levi M, Davidson BL, Palareti G; Pulmonary Embolism Dyspnea Italian Study (PEDIS) Investigators. Prevalence of pulmonary embolism among patients with recent onset of dyspnea on exertion. A cross-sectional study. J Thromb Haemost. 2023

Poli D, Antonucci E, Ageno W, Prandoni P, Barillari G, Bitti G, Imbalzano E, Bucherini E, Chistolini A, Fregoni V, Galliazzo S, Gandolfo A, Grifoni E, Mastroianni F, Panarello S, Pesavento R, Pedrini S, Sala G, Pignatelli P, Preti P, Simonetti F, Sivera P, Visonà A, Villalta S, Marcucci R, Palareti G. Thromboembolic Complications in COVID-19 Patients Hospitalized in Italian Ordinary Wards: Data from the Multicenter Observational START-COVID Register. TH Open. 2022

Fumagalli RM, Aimasso U, Valeriani E, Mumoli N, Szlaszynska M, Antonucci E, Palareti G, Mastroiacovo D, Di Nisio M, Barco S. Quality of warfarin anticoagulation in adults with short bowel syndrome on home parenteral nutrition. Vasa. 2022

Palareti G, Poli D, Ageno W, Legnani C, Antonucci E, Bucherini E, Testa S, Paoletti O, Chistolini A, Serrao A, Martinelli I, Bucciarelli P, Falanga A, Tosetto A, Sarti L, Mastroiacovo D, Cosmi B, Visonà A, Santoro RC, Zanatta N, Grandone E, Bertù L, Pengo V, Caiano L, Prandoni P. D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study. Blood Adv 2022

Legnani C, Cini M, Testa S, Tosetto A, Dellanoce C,  Bellesso S, Carli G, Nichele I, Lissandrini L, Zorzi S, Antonucci E, Palareti G. Evaluation of Coaguchek®Pro II coagulation testing device performance to assess direct oral anticoagulant action. The DOAC-CHECK study. BTVB 2022

Pastori D, Antonucci E, Milanese A, Menichelli D, Palareti G, Farcomeni A, Pignatelli P. The Start Register Investigators Clinical Phenotypes of Atrial Fibrillation and Mortality Risk-A Cluster Analysis from the Nationwide Italian START Registry. J Pers Med. 2022

Poli D, Antonucci E,   Palareti G , Facchinetti R, Falco P, Serricchio G, Lerede T, Masciocco L, Gresele P, Sophie T. Major bleedings in mechanical prosthetic heart valves patients on Vitamin K antagonist treatment. Data from the PLECTRUM Study. BTVB 2022

Palareti G, Bignamini AA, Urbanek T, Cini M, Li YJ, Madaric J, Bouslama K, Sokurenko GY, Andreozzi GM, Matuška J, Mansilha A, Barinov V; WHITE study group. Influence of clinical presentation, site, and extent of venous thrombosis on decision about duration of anticoagulation: Data from the international, prospective, observational WHITE study. Thromb Res. 2022

Menichelli D, Poli D, Antonucci E, Biccirè FG, Palareti G, Pignatelli P, Pastori D.  Bleeding and mortality risk in patients implanted with mechanical prosthetic heart valves with and without thrombocytopenia. Insights from the nationwide PLECTRUM registry Platelets. 2022

Palareti G, Bignamini A, Cini M, Li YJ, Urbanek T, Madaric J, Bouslama K, Sokurenko GY, Andreozzi GM, Matuška J, Mansilha A, Barinov V; WHITE study group. Unprovoked or provoked venous thromboembolism: not the prevalent criterion to decide on anticoagulation extension in clinical practice of various countries-the prospective, international, observational WHITE study. Intern Emerg Med. 2022

Poli D, Antonucci E, Ageno W, Prandoni P, Palareti G, Marcucci R; START-COVID Investigators. Low in-hospital mortality rate in patients with COVID-19 receiving thromboprophylaxis: data from the multicentre observational START-COVID Register. Intern Emerg Med. 2022

Cesaro A, Gragnano F, Calabrò P, Moscarella E, Santelli F, Fimiani F, Patti G, Cavallari I, Antonucci E, Cirillo P, Pignatelli P, Palareti G, Pelliccia F, Bossone E, Pengo V, Gresele P, Marcucci R; START-ANTIPLATELET collaborators. Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry. Intern J Cardiol 2021

Legnani C, Palareti G, Antonucci E, Poli D, Cosmi B, Falanga A, Mastroiacovo D, Testa S; START 2-Register Investigators (Appendix 1). Thrombophilia testing in the real-world clinical setting of thrombosis centres taking part in the Italian Start 2-Register. Blood Transfus. 2021

Palareti G, Bignamini AA, Cini M, Li YJ, Urbanek T, Madaric J, Bouslama K, Sokurenko GY, Andreozzi GM, Matuška J, Mansilha A, Barinov V. Anticoagulation Duration After First Venous Thromboembolism: Real-Life Data from the International, Observational WHITE Study. Clin Appl Thromb Hemost. 2021

Poli D, Migliaccio L, Antonucci E, Biancone L, Bozzolin A, Corradetti V, Finale C, Furian L, La Manna G, Larti A, Ranghino A, Rossetti MM, Taruscia D, Palareti G, Zanazzi M. Venous thromboembolism in renal transplant recipients: Results of Venous thromboEmbolism in renal Transplant Recipients- Italian Study – VETRIS. Thromb Res. 2021

Palareti G, Legnani C, Antonucci E, Cosmi B, Falanga A, Poli D, Mastroiacovo D, Pengo V, Ageno W, Testa S. Do women with venous thromboembolism bleed more than men during anticoagulation? Data from the real-life, prospective START-Register. Ther Adv Drug Saf. 2021

Palareti G., Legnani C., Antonucci E., Testa S., Mastroiacovo D., Cosmi B, Poli D., Bucherini E. Pomero F., Fontanella A, Mumoli N,Imberti D, Ageno W., Falanga A, Dentali F. Isolated Distal Deep Vein Thromboses: A Questionable Trend Towards Long-Lasting Anticoagulant Therapy. Results From A Prospective, Observational Italian Register TH open 2021

Menichelli D, Poli D, Antonucci E, Pignatelli P, Palareti G, Testa S, Pastori D and the Italian Federation of Anticoagulation Clinics (FCSA) Comparison of anticoagulation quality between acenocoumarol and warfarin in patients with mechanical prosthetic heart valves: insights from the nationwide PLECTRUM study. Molecules 2021

Pastori D, Poli D, Antonucci E, Menichelli D, Palareti G, Violi F, Pignatelli P, Sex-based difference in anticoagulated patients with mechanical prosthetic heart valves and long-term mortality risk . Int J Clin Pract. 2021

Poli D, Antonucci E,  Pengo V, Bucherini E,  Ldigiani C,  Barcellona D,  Palareti G, Testa S on the behalf of the Italian Federation of Anticoagulation Clinics (FCSA) Association of antiplatelet and anticoagulant treatment in patients with Mechanical Prosthetic Heart Valves. Data from the observational multicentre PLECTRUM Study. Cardiol Cardiovasc Med 2021

Cavallari I, Maddaloni E, Gragnano F, Patti G, Antonucci E, Calabrò P, Cirillo P, Gresele P, Palareti G, Pengo V, Pignatelli P, Marcucci R; START-ANTIPLATELET collaborators. Ischemic and bleeding risk by type 2 diabetes clusters in patients with acute coronary syndrome. Inter Emerg Med 2021

Gresele P, Guglielmini G, Del Pinto M, Calabrò P, Pignatelli P, Patti G, Pengo V, Antonucci E, Cirillo P, Fierro T, Palareti G, Marcucci R; START Antiplatelet Registry Group. Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry. Int Journ Cardiol 2020

Antonucci E, Migliaccio L, Abbattista M, Caronna A, De Marchi S, Di Giorgio A, Di Giulio R, Lerede T, Garzia MG, Martinelli I, Mastroiacovo D, Marzolo M, Montevecchi E, Pastori D, Pignatelli P, Poli D, Ria L, Santoliquido A, Testa S, Palareti G; START POST VTE Investigators. Treatment decision-making of secondary prevention after venous thromboembolism: data from the real life START2- Post VTE Registry. Clin App Th Haem 2020

Margaglione M, Antonucci E, D’Andrea G, Migliaccio L, Ageno W, Bucherini E, Cosmi B, Falanga A, Martini G, Mastroiacovo D, Paparo C, Poli D, Testa S, Palareti G. Anticoagulation in Italian patients with venous thromboembolism and thrombophilic alterations: findings from START2 register study. Blood Transfusion 2020

Poli D, Antonucci E, Vignini E, Martinese L, Testa S, Simioni P, Pengo V, Pignatelli P, Falanga A, Masciocco L, Barcellona D, Ciampa A, Chiarugi P, Paparo C, Ageno W, Palareti G; START2 Registry investigators.Anticoagulation resumption after intracranial hemorrhage in patients treated with VKA and DOACs. Eur J Int Med 2020

Gragnano F, Moscarella E, Calabrò P, Cesaro A, Pafundi PC, Ielasi A, Patti G, Cavallari I, Antonucci E, Cirillo P, Pignatelli P, Palareti G, Pelliccia F, Gaudio C, Sasso FC, Pengo V, Gresele P, Marcucci R; START-ANTIPLATELET Collaborators. Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry.  Intern Emerg Med. 2020

Cini M, Legnani C, Padrini R, Cosmi B, Dellanoce C, De Rosa G, Marcucci R, Pengo V, Poli D, Testa S, Palareti G. DOAC plasma levels measured by chromogenic anti-Xa assays and HPLC in apixaban and rivaroxaban treated patients from the START-Register. Int J Lab Hematol 2020

Pastori D, Lip GYH, Poli D, Antonucci E, Rubino L, Menichelli D, Saliola M, Violi F, Palareti G, Pignatelli P; Italian Federation of Anticoagulation Clinics (FCSA). Determinants of low-quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. The nationwide PLECTRUM study. British J Hematol  2020

Palareti G, Legnani C, Antonucci E, Zorzi S, Bignamini AA, Lodigiani C, Tosetto A, Bertù L, Pengo V, Testa S, Ageno W, Prisco D, Prandoni P, Poli D.  Design and rationale of a randomized, placebo-controlled trial on the efficacy and safety of sulodexide for extended treatment in elderly patients after a first venous thromboembolism. Intern Emerg Med 2020

Cirillo P, Di Serafino L, Taglialatela V, Calabrò P, Antonucci E, Gresele P, Palareti G, Patti G, Pengo V, Pignatelli P, Marcucci R. Optimal Medical Therapy on Top of Dual-Antiplatelet Therapy: 1-Year Clinical Outcome in Patients With Acute Coronary Syndrome: The START Antiplatelet. Angiology 2020

Palareti G, Legnani C, Antonucci E, Cosmi B, Poli D, Testa S, Tosetto A, Ageno W, Falanga A, Ferrini PM, Pengo V, Prandoni P; DULCIS (D-dimer and ULtrasonography in Combination Italian Study) Investigators. D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study. Intern Emerg Med 2020

Palareti G, Antonucci E, Dentali F, Mastroiacovo D, Mumoli N, Pengo V, Poli D, Testa S, Pujatti PL, Menditto VG, Imberti D, Fontanella A. Patients with Isolated Pulmonary Embolism in Comparison to those with Deep Venous Thrombosis. Differences in Characteristics and Clinical Evolution. Eur J Int Med 2019

Pastori D, Antonucci E, Violi F, Palareti G, Pignatelli P; START2 Registry Investigators. Thrombocytopenia and Mortality Risk in Patients With Atrial Fibrillation: An Analysis From the START Registry J Am Heart Ass 2019

Calabrò P, Moscarella E, Gragnano F, Cesaro A, Pafundi PC, Patti G, Cavallari I, Antonucci E, Cirillo P, Pignatelli P, Palareti G, Sasso FC, Pengo V, Gresele P, Marcucci R; START-ANTIPLATELET collaborators, Conte M, Fimiani F, Di Serafino L, Del Pinto M, Denas G, Pastori D, Eleonora C, Fierro T.Effect of Body Mass Index on Ischemic and Bleeding Events in Patients Presenting With Acute Coronary Syndromes (from the START-ANTIPLATELET Registry) Am J Cardiol 2019

Legnani C, Martinelli I, Palareti G, Ciavarella A, Poli D, Ageno W, Testa S, Mastroiacovo D, Ciammaichella M, Bucherini E, Mumoli N, Cosmi B. D-dimer levels during and after anticoagulation withdrawal in patients with venous thromboembolism treated with non-vitamin K anticoagulants PlosOne 2019

Poli D, Antonucci E, Bertù L, Vignini E, Ruocco L, Mastroiacovo D, Paparo C, Pastori D, Testa S, Ageno W, Palareti G; coordinator of START2 Register. Very elderly patients with venous thromboembolism on oral anticoagulation with VKAS or DOACS: results from the prospective multicenter START2-Register Study. Thromb Res 2019

Marcucci R, Patti G, Calabrò P, Gori AM, Grossi G, Cirillo P, Pengo V, Gresele P, Pignatelli P, Antonucci E, di Mario C, Valente S, Palareti G. Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry. Plos One 2019

Poli D, Antonucci E, Ageno W, Bertù L, Migliaccio L, Martinese L, Pilato G, Testa S, Palareti G. Oral anticoagulation with VKAs or DOACs in very elderly patients with atrial fibrillation. Results from the prospective multicenter START2 Register study. PLosOne 2019

Testa S, Legnani C, Antonucci E, Paoletti O, Dellanoce C, Cosmi B, Pengo V, Poli D, Morandini R, Testa R, Tripodi A, Palareti G; Coordinator of START2-Register. Drug Levels And Bleeding Complications In Atrial Fibrillation Patients Treated With Direct Oral Anticoagulants. J Thromb Haemost 2019

Testa , C. Dellanoce, O. Paoletti, E. Cancellieri, R. Morandini, M. Tala, S. Zambelli, C. Legnani. Edoxaban plasma levels in patients with non-valvular atrial fibrillation: inter and intra-individual variability, correlation with coagulation screening test and renal function. Thromb Res 2019

Cini M, Legnani C, Testa S, Tripodi A, Cosmi B, Palareti G. An in-vitro study to investigate the interference of enoxaparin on plasma levels of direct oral factor Xa inhibitors measured by chromogenic assays. Intern Journ  Lab Hemat 2019

Cirillo P, Di Serafino L, Patti G, Antonucci E, Calabrò P, Gresele P, Palareti G, Pengo V, Pignatelli P, Marcucci R. Gender-Related Differences in Antiplatelet Therapy and Impact on 1-Year Clinical Outcome in Patients Presenting With ACS: The START ANTIPLATELET Registry Angiology 2019

Palareti G Antonucci E, Mastroiacovo D, Ageno W, Pengo V, Poli D, Testa S, Tosetto A, Prandoni P. ACCP score to assess the risk of bleeding during anticoagulation: application to real-life data from the START2-REGISTRY. J Thromb Haemost, 2018

Poli D, Antonucci E, Pengo V, Grifoni E, Maggini N, Testa S, Lodigiani C, Insana A, Marongiu F, Barcellona D, Paparo C, Bucherini E, Pignatelli P, Palareti G, on the behalf of the Italian Federation of Anticoagulation Clinics. High risk for reoperation among patients with bioprosthetic heart valves and indication for long-term anticoagulation. Open Heart, 2018

Testa S, Ageno W, Antonucci E, Morandini R, Beyer-Westendorf J, Paciaroni M, Righini M, Sivera P, Verhamme P, Pengo V, Poli D, Palareti G. Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: results from the START-Events Registry. Intern Emerg Med 2018

Poli D, Antonucci E, Pengo V, Migliaccio L, Testa S, Lodigiani L, Coffetti N, Facchinetti R, Serricchio G, Falco P, Mangione C, Masottini S, Ruocco L, De Caterina R, Palareti G coordinator of START Registry, on  the behalf of the Italian Federation of Anticoagulation Clinics. Mechanical Prosthetic Heart Valves: quality of anticoagulation and thromboembolic risk.  The observational  multicentre PLECTRUM Study. Int J Cardiol 2018

Testa S, Paoletti O, Cristina Legnani, Dellanoce C, Antonucci E, Cosmi B, Pengo V, Poli D, Morandi R, Testa R, Tripodi A, Palareti G Coordinator of START Registry. Low drug levels and thrombotic complications in high risk atrial fibrillation patients treated with direct oral anticoagulants. J Thromb Haemost 2018

Patti G, Ricottini E, Nenna A, Cavallari I, Antonucci E, Calabrò P, Cirillo P, Gresele P, Palareti G, Pengo V, Pignatelli P, Bisignani A, Marcucci R. Impact of Chronic Renal Failure on Ischemic and Bleeding Events at 1 Year in Patients With Acute Coronary Syndrome (from the Multicenter START ANTIPLATELET Registry).Am J Cardiol 2018

Calabrò P, Gragnano F, Di Maio M, Patti G, Antonucci E, Cirillo P, Gresele P, Palareti G, Pengo V, Pignatelli P, Pennacchi M, Granatelli A, De Servi S, De Luca L, Marcucci R; for EYESHOT Study and Start Antiplatelet Register. Epidemiology and Management of Patients With Acute Coronary Syndromes in Contemporary Real-World Practice: Evolving Trends From the EYESHOT Study to the START-ANTIPLATELET Registry. Angiology 2018

Cini M, Legnani C, Cosmi B, Testa S, Dellanoce C, Paoletti O, Marcucci R, Poli D, Paniccia R, Pengo V, Tripodi A, Palareti G; START-Laboratory Register. Comparison of five specific assays for determination of dabigatran plasma concentrations in patients enrolled in the START-Laboratory Register. International Journal of Laboratory Hematology, 2018

Gentian D, Zoppellaro G, Padayattil Jose S, Antonucci E, Marongiu F, Poli D, Testa S, Tripodi A, Palareti G, Pengo V. Warfarin prescription in patients with non-valvular atrial fibrillation and one non-gender related risk factor (CHA2DS2VASc 1 or 2): a treatment dilemma. Cardiovascular Therapeutics, 2017

Patti G, Cavallari I, Antonucci E, Calabrò P, Cirillo P, Gresele P, Palareti G, Pengo V, Pignatelli P, Ricottini E, Marcucci R. Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome   PLoS One 2017

Palareti G, Antonucci E, Migliaccio L, Erba N, Marongiu F, Pengo V, Poli D, Testa S, Tosetto A, Tripodi A, Moia M; on behalf of the centres participating in the FCSA-START-Register (The ISCOAT 2016 study).Vitamin K Antagonist Therapy: Changes in the Treated Populations and in Management Results in Italian Anticoagulation Clinics Compared with those recorded 20 years ago. Intern and Emerg Med, 2017

Poli D, Antonucci E, Pengo V, Testa S, Palareti G. Comparison of HAS-BLED and HAS-BED Versus CHADS2 and CHA2DS2VASC Stroke and Bleeding Scores in patients with atrial fibrillation. Am J Cardiol 2017

Testa S, Tripodi A, Legnani C, Pengo V, Abbate R, Dellanoce C, Carraro P, Salomone L, Paniccia R, Paoletti O, Poli D, Palareti G; START-Laboratory Register. Plasma levels of direct oral anticoagulants in real life patients with atrial fibrillation: Results observed in four anticoagulation clinics. Thromb  Res 2016

Palareti G, Cosmi B, Antonucci E, Legnani C, Erba N, Ghirarduzzi A, Poli D, Testa S, Tosetto A, Pengo V, Prandoni P; DULCIS investigators. Duration of anticoagulation after isolated pulmonary embolism Eur Respir J 2016

Testa S, Legnani C, Tripodi A, Paoletti O, Pengo V, Abbate R, Bassi L, Carraro P, Cini M, Paniccia R, Poli D, Palareti G. Poor comparability of coagulation screening test with specific measurement in patients on direct oral anticoagulants: results from a multicenter/multiplatform study. J Thromb Haemost 2016

Palareti G, Antonucci E, Lip GY, Testa S, Guazzaloca G, Falanga A, Pengo V, Poli D; START-Register Participants. The SAME-TT2R2 score predicts the quality of anticoagulation control in patients with acute VTE. A real-life inception cohort study. Thromb Haemost 2016

Antonucci E, Poli D, Tosetto A, Pengo V, Tripodi A, Magrini N, Marongiu F, Palareti G; START-Register.The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation. PLosOne 2015

ARTICOLI Gruppo TRIP

Ageno W, Bertù L, Bucherini E, Camporese G, Dentali F, Iotti M, Lessiani G, Parisi R, Prandoni P, Sartori M, Visonà A, Bigagli E, Palareti G; RIDTS study group. Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial. BMJ. 2022 

Tosetto A, Testa S, Martinelli I, Poli D, Cosmi B, Lodigiani C, Ageno W, De Stefano V, Falanga A, Nichele I, Paoletti O, Bucciarelli P, Antonucci E, Legnani C, Banfi E, Dentali F, Bartolomei F, Barcella L, Palareti G. External validation of the DASH prediction rule: a retrospective cohort study. J Thromb Haemost. 2017